Equillium, Inc. (EQ)
EQ Stock Price Chart
Explore Equillium, Inc. interactive price chart. Choose custom timeframes to analyze EQ price movements and trends.
EQ Company Profile
Discover essential business fundamentals and corporate details for Equillium, Inc. (EQ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
12 Oct 2018
Employees
35.00
Website
https://equilliumbio.comCEO
Bruce D. Steel
Description
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib clinical trial for the treatment of asthma disease; and Phase Ib clinical trial for the treatment of and lupus nephritis. It also develops EQ101 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ102 to treat various gastrointestinal diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
EQ Financial Timeline
Browse a chronological timeline of Equillium, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 12 Nov 2025
EPS estimate is -$0.14.
Earnings released on 14 Aug 2025
EPS came in at -$0.16 falling short of the estimated -$0.14 by -14.29%.
Earnings released on 14 May 2025
EPS came in at -$0.24 falling short of the estimated -$0.23 by -4.35%.
Earnings released on 27 Mar 2025
EPS came in at -$0.16 surpassing the estimated -$0.22 by +27.27%, while revenue for the quarter reached $4.39M .
Earnings released on 13 Nov 2024
EPS came in at -$0.00 surpassing the estimated -$0.26 by +99.92%, while revenue for the quarter reached $12.16M , beating expectations by +5.29%.
Earnings released on 8 Aug 2024
EPS came in at $0.01 surpassing the estimated -$0.15 by +106.67%, while revenue for the quarter reached $13.85M , missing expectations by -35.27%.
Earnings released on 9 May 2024
EPS came in at -$0.08 surpassing the estimated -$0.17 by +52.94%, while revenue for the quarter reached $10.69M , beating expectations by +18.77%.
Earnings released on 25 Mar 2024
EPS came in at -$0.07 surpassing the estimated -$0.17 by +58.82%, while revenue for the quarter reached $9.21M , beating expectations by +15.14%.
Earnings released on 8 Nov 2023
EPS came in at -$0.11 surpassing the estimated -$0.16 by +31.25%, while revenue for the quarter reached $8.87M , beating expectations by +10.88%.
Earnings released on 9 Aug 2023
EPS came in at -$0.10 surpassing the estimated -$0.19 by +47.37%, while revenue for the quarter reached $9.12M , beating expectations by +14.05%.
Earnings released on 11 May 2023
EPS came in at -$0.11 surpassing the estimated -$0.20 by +45.00%, while revenue for the quarter reached $8.88M , beating expectations by +93.02%.
Earnings released on 23 Mar 2023
EPS came in at $0.08 surpassing the estimated $0.02 by +407.61%, while revenue for the quarter reached $15.76M , missing expectations by -58.53%.
Earnings released on 14 Nov 2022
EPS came in at -$0.40 falling short of the estimated -$0.39 by -2.56%.
Earnings released on 15 Aug 2022
EPS came in at -$0.41 falling short of the estimated -$0.40 by -2.50%.
Earnings released on 12 May 2022
EPS came in at -$0.45 falling short of the estimated -$0.36 by -25.00%.
Earnings released on 23 Mar 2022
EPS came in at -$0.36 falling short of the estimated -$0.34 by -5.88%.
Earnings released on 10 Nov 2021
EPS came in at -$0.35 falling short of the estimated -$0.34 by -2.94%.
Earnings released on 10 Aug 2021
EPS came in at -$0.31 matching the estimated -$0.31.
Earnings released on 13 May 2021
EPS came in at -$0.33 surpassing the estimated -$0.34 by +2.94%.
Earnings released on 24 Mar 2021
EPS came in at -$0.36 surpassing the estimated -$0.38 by +5.26%.
Earnings released on 10 Nov 2020
EPS came in at -$0.31 surpassing the estimated -$0.41 by +24.39%.
EQ Stock Performance
Access detailed EQ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.